Piramal Pharma Limited (PPLPHARMA.NS)

INR 260.5

(-1.59%)

Annual Income Statements

(In INR)
Breakdown 2024 2023 2022 2021
Revenue 81.71 Billion 70.81 Billion 30.95 Billion 29.38 Billion
Cost of Revenue 57.24 Billion 27.03 Billion 15.49 Billion 12.78 Billion
Gross Profit 24.47 Billion 43.78 Billion 15.46 Billion 16.6 Billion
Operating Expenses 19.91 Billion 44.26 Billion 12.78 Billion 11.79 Billion
Selling, General and Administrative Expenses 5.66 Billion 5.52 Billion 2.36 Billion 1.81 Billion
Research and Development Expenses 1 Billion 863.6 Million 619.4 Million 691.4 Million
Other Expenses 1.75 Billion 2.25 Billion 654.1 Million 153 Million
Cost and Expenses 77.15 Billion 71.3 Billion 28.27 Billion 24.58 Billion
Operating Income 4.31 Billion 141.5 Million 5.6 Billion 5.5 Billion
Interest Expense 4.46 Billion 3.44 Billion 1.98 Billion 47.1 Million
Income Tax Expense 1.61 Billion 663.1 Million 811.8 Million 1.15 Billion
Earnings before Tax 1.79 Billion -1.2 Billion 4.24 Billion 6.86 Billion
Net Income 178.2 Million -1.86 Billion 3.75 Billion 5.71 Billion
Earnings Per Share Basic 0.14 -1.53 3.11 4.68
Earnings Per Share Diluted 0.14 -1.53 3.11 4.68
Weighted Average Shares Outstanding 1.27 Billion 1.21 Billion 1.2 Billion 1.21 Billion
Weighted Average Shares Outstanding (Diluted) 1.28 Billion 1.21 Billion 1.2 Billion 1.22 Billion
Gross Margin 0.30 0.62 0.50 0.57
EBIT Margin 0.16 0.13 0.13 0.21
Profit Margin 0.00 -0.03 0.12 0.19
EBITDA 13.05 Billion 8.46 Billion 12.1 Billion 6.11 Billion
Earnings Before Tax Margin 0.05 0.00 0.18 0.19

Income Statement Charts